Etiology and microbial patterns of pulmonary infiltrates in patients with orthotopic liver transplantation

Chest. 2000 Feb;117(2):494-502. doi: 10.1378/chest.117.2.494.

Abstract

Study objective: To evaluate the etiology and microbial patterns of pulmonary infiltrates in liver transplant patients using a bronchoscopic diagnostic approach and the impact of diagnostic results on antimicrobial treatment decisions.

Design: A prospective cohort study.

Setting: A 1,000-bed tertiary-care university hospital.

Patients and methods: Fifty consecutive liver transplant patients with 60 episodes of pulmonary infiltrates (33 episodes during mechanical ventilation) were studied using flexible bronchoscopy with protected specimen brush (PSB) and BAL.

Results: A definite infectious etiology was confirmed in 29 episodes (48%). Eighteen episodes corresponded to probable pneumonia (30%), 10 episodes had noninfectious etiologies (17%), and 3 remained undetermined (5%). Opportunistic infections were the most frequent etiology (16/29, 55%, including 1 mixed etiology). Bacterial infections (mainly Gram-negative) accounted for 14 of 29 episodes (48%), including 1 of mixed etiology. The majority of bacterial pneumonia episodes (n = 10, 71%) occurred in period 1 (1 to 28 days posttransplant) during mechanical ventilation, whereas opportunistic episodes were predominant in periods 2 and 3 (29 to 180 days and > 180 days posttransplant, respectively; n = 14, 82%). Microbial treatment was changed according to diagnostic results in 21 episodes (35%).

Conclusions: Microbial patterns in liver transplant patients with pulmonary infiltrates corresponded to nosocomial, mainly Gram-negative bacterial pneumonia in period 1, and to opportunistic infections in period 2 and, to a lesser extent, period 3. A comprehensive diagnostic evaluation including PSB and BAL fluid examination frequently guided specific antimicrobial therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis
  • Bacteriological Techniques
  • Bronchoalveolar Lavage Fluid / microbiology
  • Bronchoscopy
  • Child
  • Cohort Studies
  • Cross Infection / drug therapy
  • Cross Infection / etiology*
  • Cross Infection / microbiology
  • Diagnosis, Differential
  • Female
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / isolation & purification
  • Hospitals, University
  • Humans
  • Liver Transplantation*
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / etiology
  • Opportunistic Infections / microbiology
  • Pneumonia / drug therapy
  • Pneumonia / etiology*
  • Pneumonia / microbiology
  • Pneumonia, Bacterial / drug therapy
  • Pneumonia, Bacterial / etiology*
  • Pneumonia, Bacterial / microbiology
  • Prospective Studies

Substances

  • Anti-Bacterial Agents